X. L. Wang

2.0k total citations · 1 hit paper
47 papers, 910 citations indexed

About

X. L. Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, X. L. Wang has authored 47 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in X. L. Wang's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). X. L. Wang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). X. L. Wang collaborates with scholars based in China, United States and Canada. X. L. Wang's co-authors include Raouf A. Khalil, Lin Lü, Bernard Le Foll, Yu Liu, Yanli Liu, Ming Chen, Shuyuan Yeh, Chawnshang Chang, Sally Radovick and Andrew Wolfe and has published in prestigious journals such as ACS Nano, PLoS ONE and Scientific Reports.

In The Last Decade

X. L. Wang

38 papers receiving 895 citations

Hit Papers

Matrix Metalloproteinases, Vascular Remodeling, and Vascu... 2017 2026 2020 2023 2017 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease
    2017 517 citations X. L. Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
X. L. Wang China 12 268 149 121 119 109 47 910
Agnes Schröder Germany 18 477 1.8× 137 0.9× 93 0.8× 135 1.1× 93 0.9× 73 1.2k
Griselda A. Cabral-Pacheco Mexico 4 338 1.3× 257 1.7× 133 1.1× 125 1.1× 108 1.0× 8 1.1k
Ivanka Dimova Bulgaria 18 488 1.8× 126 0.8× 140 1.2× 90 0.8× 130 1.2× 58 974
Emma Rodrı́guez Mexico 17 214 0.8× 158 1.1× 156 1.3× 122 1.0× 52 0.5× 41 879
Claudia Castruita-De la Rosa Mexico 8 359 1.3× 283 1.9× 135 1.1× 160 1.3× 124 1.1× 12 1.2k
Caixia Sun China 21 492 1.8× 240 1.6× 143 1.2× 193 1.6× 77 0.7× 78 1.1k
Jing Bian China 18 448 1.7× 110 0.7× 97 0.8× 82 0.7× 129 1.2× 56 996
Xue Zhang China 19 548 2.0× 125 0.8× 69 0.6× 143 1.2× 109 1.0× 86 1.2k
Magnus Grenegård Sweden 19 290 1.1× 65 0.4× 138 1.1× 275 2.3× 96 0.9× 55 1.2k

Countries citing papers authored by X. L. Wang

Since Specialization
Citations

This map shows the geographic impact of X. L. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. L. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. L. Wang more than expected).

Fields of papers citing papers by X. L. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X. L. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. L. Wang. The network helps show where X. L. Wang may publish in the future.

Co-authorship network of co-authors of X. L. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of X. L. Wang. A scholar is included among the top collaborators of X. L. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with X. L. Wang. X. L. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Rui, X. L. Wang, Jianzhong Zhu, Hao Li, & Wei Liu. (2025). Effectiveness of nucleoside analogs against Wetland virus infection. Antiviral Research. 236. 106114–106114.
2.
Zhang, Jian, Xinyan Jiang, Zhe Li, et al.. (2025). Confined Assembly of Superwettable Nanomaterials for Bioinspired Nanofluidic Membranes/Applications. ACS Nano. 19(40). 35193–35211.
3.
Wang, Xiyang, Mingrui Yuan, Deqing Fang, et al.. (2025). Development of a high resolution Time-of-Flight with SiPM-readout Scintillator in Belle II for measurement of Neutral Hadron momentum. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 1084. 171194–171194.
4.
Li, Jiao, Ziyu Wang, Jin Yan, et al.. (2025). Transmembrane channel-like 5 drives hepatocellular carcinoma progression by regulating epithelial-mesenchymal transition. World Journal of Clinical Oncology. 16(3). 94091–94091. 1 indexed citations
5.
6.
Li, Yulei, Peipei Liu, X. L. Wang, et al.. (2024). A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants. PLoS Pathogens. 20(9). e1012508–e1012508. 2 indexed citations
7.
8.
9.
Wang, X. L., et al.. (2024). Influence of ultrasonic treatment parameters on extraction yield of limonin from Wenling Gaocheng peels analysed by HPLC-UV. International Food Research Journal. 31(3). 614–623. 1 indexed citations
10.
Ding, Yi, et al.. (2024). Association of the triglyceride glucose index with myocardial ischemia in patients with minimal to moderate coronary artery disease. Scientific Reports. 14(1). 26093–26093. 4 indexed citations
11.
Zhu, Pingjun, X. L. Wang, Jianbo Zhu, et al.. (2024). BCAP31 Alleviates Lipopolysaccharide-Mediated Acute Lung Injury via Induction of PINK1/Parkin in Alveolar Epithelial Type II Cell. Research. 7. 498–498. 4 indexed citations
12.
Liu, Yun, Xueyong Wei, Tao Yang, et al.. (2024). Hyaluronic acid methacrylate/Pluronic F127 hydrogel enhanced with spermidine-modified mesoporous polydopamine nanoparticles for efficient synergistic periodontitis treatment. International Journal of Biological Macromolecules. 281(Pt 1). 136085–136085. 11 indexed citations
13.
Zhao, Yongdan, Yidan Wang, Rongrong Wang, et al.. (2023). Reversing artemisinin resistance by leveraging thermo-responsive nanoplatform to downregulating GSH. Chinese Chemical Letters. 35(6). 108929–108929. 1 indexed citations
14.
Zhao, Penghui, Qian Wang, Aixin Chen, et al.. (2021). Repeated 3,3-Dimethyl-1-butanol exposure alters social dominance in adult mice. Neuroscience Letters. 758. 136006–136006. 11 indexed citations
15.
Wang, X. L., Long Wang, Liang Zhong, et al.. (2017). Effects of neuregulin-1 on autonomic nervous system remodeling post-myocardial infarction in a rat model. Neural Regeneration Research. 12(11). 1905–1905. 6 indexed citations
16.
Zheng, Ying, X. L. Wang, Xiaolong Tan, et al.. (2014). Recognition of Bungarus multicinctus Venom by a DNA Aptamer against β-Bungarotoxin. PLoS ONE. 9(8). e105404–e105404. 27 indexed citations
17.
Zhao, Pan, Chunya Wang, Weiwei Liu, et al.. (2013). Causes and Outcomes of Acute Liver Failure in China. PLoS ONE. 8(11). e80991–e80991. 58 indexed citations
18.
Xie, Xinhua, Jiaoli Guo, Yanan Kong, et al.. (2011). Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy. The Journal of Gene Medicine. 13(12). 680–691. 17 indexed citations
19.
Yu, Hui, Chun Zhang, Xia Fan, et al.. (2010). Evodiamine as a novel antagonist of aryl hydrocarbon receptor. Biochemical and Biophysical Research Communications. 402(1). 94–98. 15 indexed citations
20.
Chen, Ming, Andrew Wolfe, X. L. Wang, et al.. (2008). Generation and characterization of a complete null estrogen receptor α mouse using Cre/LoxP technology. Molecular and Cellular Biochemistry. 321(1-2). 145–153. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agnes Schröder Breakdown of academic impact, for papers by Griselda A. Cabral-Pacheco Breakdown of academic impact, for papers by Ivanka Dimova Breakdown of academic impact, for papers by Emma Rodrı́guez Breakdown of academic impact, for papers by Claudia Castruita-De la Rosa Breakdown of academic impact, for papers by Caixia Sun Breakdown of academic impact, for papers by Jing Bian Breakdown of academic impact, for papers by Xue Zhang Breakdown of academic impact, for papers by Magnus Grenegård
Rankless by CCL
2026